Annual Operating Expenses
$93.00 M
+$21.14 M+29.42%
December 31, 2022
Summary
- As of February 10, 2025, GRCL annual total operating expenses is $93.00 million, with the most recent change of +$21.14 million (+29.42%) on December 31, 2022.
- During the last 3 years, GRCL annual operating expenses has risen by +$71.78 million (+338.23%).
Performance
GRCL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$16.83 M
-$3.31 M-16.46%
September 30, 2023
Summary
- As of February 10, 2025, GRCL quarterly total operating expenses is $16.83 million, with the most recent change of -$3.31 million (-16.46%) on September 30, 2023.
- Over the past year, GRCL quarterly operating expenses has dropped by -$3.31 million (-16.46%).
Performance
GRCL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
GRCL Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.4% | -16.5% |
| 3 y3 years | +338.2% | -16.5% |
| 5 y5 years | +883.6% | -16.5% |
GRCL Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -22.7% | -33.0% | at low |
| 5 y | 5-year | at high | -77.2% | -33.0% | -71.9% |
| alltime | all time | at high | -89.8% | -33.0% | -71.9% |
Gracell Biotechnologies Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $16.83 M(-16.5%) |
| Jun 2023 | - | $20.14 M(-17.3%) |
| Mar 2023 | - | $24.34 M(+16.0%) |
| Dec 2022 | $93.00 M(+29.4%) | $20.99 M(-15.3%) |
| Sep 2022 | - | $24.79 M(+12.4%) |
| Jun 2022 | - | $22.06 M(-12.2%) |
| Mar 2022 | - | $25.13 M(+15.2%) |
| Dec 2021 | $71.85 M | $21.81 M(+7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $20.30 M(+37.1%) |
| Jun 2021 | - | $14.81 M(-1.1%) |
| Mar 2021 | - | $14.98 M(+16.2%) |
| Dec 2020 | $31.07 M(+46.4%) | $12.89 M(+85.3%) |
| Sep 2020 | - | $6.96 M(+3.3%) |
| Jun 2020 | - | $6.74 M(+42.6%) |
| Mar 2020 | - | $4.72 M(-27.5%) |
| Dec 2019 | $21.22 M(+124.4%) | $6.51 M |
| Dec 2018 | $9.46 M | - |
FAQ
- What is Gracell Biotechnologies annual total operating expenses?
- What is the all time high annual operating expenses for Gracell Biotechnologies?
- What is Gracell Biotechnologies annual operating expenses year-on-year change?
- What is Gracell Biotechnologies quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Gracell Biotechnologies?
- What is Gracell Biotechnologies quarterly operating expenses year-on-year change?
What is Gracell Biotechnologies annual total operating expenses?
The current annual operating expenses of GRCL is $93.00 M
What is the all time high annual operating expenses for Gracell Biotechnologies?
Gracell Biotechnologies all-time high annual total operating expenses is $93.00 M
What is Gracell Biotechnologies annual operating expenses year-on-year change?
Over the past year, GRCL annual total operating expenses has changed by +$21.14 M (+29.42%)
What is Gracell Biotechnologies quarterly total operating expenses?
The current quarterly operating expenses of GRCL is $16.83 M
What is the all time high quarterly operating expenses for Gracell Biotechnologies?
Gracell Biotechnologies all-time high quarterly total operating expenses is $25.13 M
What is Gracell Biotechnologies quarterly operating expenses year-on-year change?
Over the past year, GRCL quarterly total operating expenses has changed by -$3.31 M (-16.46%)